Health Insights Research

  The India hospital market is witnessing robust expansion due to the increasing burden of chronic and infectious diseases, a growing aging population, rapid urbanization, and rising healthcare expenditure. Valued at USD 98.98 billion in 2024 , the market is anticipated to reach USD 173.94 billion by 2034 , growing at a CAGR of 5.80% during the forecast period of 2025–2034. India’s healthcare system has evolved into one of the largest sectors in terms of employment and revenue. The sector’s rapid transformation is being driven by government initiatives like Ayushman Bharat , Pradhan Mantri Jan Arogya Yojana (PM-JAY) , and the National Health Mission (NHM) , alongside rising private investment in hospital infrastructure and technology-driven healthcare delivery systems. Overview of the India Hospital Market The hospital industry in India plays a vital role in the nation’s healthcare delivery system, offering both preventive and curative care. It includes public, private, and semi...

 The Asia Pacific vaccine marke t is rapidly growing as healthcare systems strengthen immunization programs, governments expand vaccination coverage, and pharmaceutical innovations accelerate. The Asia Pacific vaccine market was valued at USD 4.56 billion in 2024 , fueled by the increasing incidence of infectious diseases, advancements in biotechnology, and the introduction of next-generation vaccines. The market is projected to grow at a CAGR of 7.80% during 2025–2034 , reaching approximately USD 9.66 billion by 2034 . India plays a pivotal role in this growth, serving as one of the world’s largest vaccine producers. With companies such as Serum Institute of India , Bharat Biotech , and Biological E. Limited leading production and export efforts, India’s vaccine manufacturing capacity significantly contributes to the Asia Pacific region’s healthcare resilience. Overview of the Asia Pacific Vaccine Market The Asia Pacific region has witnessed transformative growth in vaccination ...

 The shock wave therapy device market is emerging as a significant segment within the medical devices industry, driven by the increasing adoption of non-invasive treatment technologies for orthopedic, urological, dermatological, and cardiac applications. This technology, known for its efficiency in pain management, tissue regeneration, and rehabilitation, is rapidly becoming a preferred alternative to surgical procedures. The shock wave therapy device market was valued at USD 168.17 million in 2024 and is projected to reach USD 281.86 million by 2034 , growing at a CAGR of 5.30% during the forecast period of 2025–2034 . This growth is largely fueled by rising sports injuries, musculoskeletal disorders, and technological innovations in medical treatment devices. Overview of the Shock Wave Therapy Device Market Shock wave therapy devices deliver acoustic energy waves to targeted tissues to stimulate healing, reduce pain, and enhance circulation. These devices are extensively used...

  The haemoglobinopathies market is witnessing significant expansion due to the rising global prevalence of genetic blood disorders such as thalassemia and sickle cell disease (SCD) . In 2024, the market was valued at USD 6.90 billion , and it is projected to grow at a CAGR of 9.70% from 2025 to 2034 , reaching approximately USD 17.41 billion by 2034. The growing availability of advanced genetic therapies, increasing screening programs, and supportive government initiatives are transforming patient outcomes and driving strong market growth. Haemoglobinopathies, a group of inherited disorders affecting the structure or production of hemoglobin, include thalassemia , sickle cell anemia , and other rare variants. With the rapid progress of gene therapy and bone marrow transplantation , the global haemoglobinopathies treatment landscape is evolving to provide curative options beyond conventional management. Overview of the Global Haemoglobinopathies Market The global haemoglobinopa...

 The   clinical trial imaging market is expanding rapidly as imaging technologies become increasingly crucial to drug development and clinical research. In 2024, the market was valued at USD 1.42 billion , and it is forecasted to reach USD 3.01 billion by 2034 , growing at a CAGR of 7.80% from 2025 to 2034. Clinical trial imaging plays a pivotal role in evaluating disease progression, monitoring therapeutic response, and improving the accuracy of clinical outcomes. With the rising prevalence of cancer, cardiovascular, and neurovascular diseases , imaging modalities such as MRI, CT, and ultrasound are increasingly integrated into multicenter trials to ensure precision and consistency. Overview of the Clinical Trial Imaging Market The clinical trial imaging market encompasses a range of technologies and services designed to collect, manage, and analyze medical images generated during clinical studies. These solutions are essential for ensuring data quality, regulatory complia...

 Understanding the brain cancer epidemiology forecast is crucial for healthcare professionals, researchers, and policymakers to design effective prevention, diagnosis, and treatment strategies. Brain cancer remains one of the most challenging malignancies due to its aggressive nature, high recurrence rates, and limited treatment options. In 2023 , brain cancer ranked as the 10th leading cause of cancer-related deaths among men and women globally. The United States alone recorded around 94,390 new cases of primary brain tumors, with the median age at diagnosis being 61 years . As medical advancements continue and healthcare awareness rises, understanding the epidemiological trends of brain cancer provides valuable insights into its future burden across key regions like the U.S., Germany, France, Italy, Spain, the U.K., Japan, and India . Brain Cancer Epidemiology Forecast Overview The brain cancer epidemiology forecast examines trends related to incidence, prevalence, mortalit...

  The ambulatory surgical centers market (ASCs) is transforming global healthcare delivery by providing cost-effective, high-quality, and efficient surgical care outside traditional hospital settings. In 2024, the market reached a valuation of USD 103.89 billion and is projected to grow at a CAGR of 4.60% between 2025 and 2034, achieving USD 162.89 billion by 2034 . Ambulatory surgical centers are redefining patient experience by offering same-day surgical procedures with advanced medical technology, shorter recovery times, and reduced healthcare costs. This model of care is gaining immense popularity due to the rising prevalence of chronic conditions, increased healthcare expenditures, and technological innovation in minimally invasive surgeries. This detailed report explores the market size, segmentation, growth drivers, emerging trends, challenges, regional performance, key players , and future outlook of the global ambulatory surgical centers market. Ambulatory Surgical Cent...